Accelerate Diagnostics Inc

+0.59 (+11.43%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)92.06M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3.55 Million
Adjusted EPS-$1.07
See more estimates
10-Day MA$5.60
50-Day MA$6.56
200-Day MA$6.71
See more pivots

Accelerate Diagnostics Inc Stock, NASDAQ:AXDX

3950 South Country Club Road, Suite 470, Tucson, Arizona 85714
United States of America
Phone: +1.520.365.3100
Number of Employees: 179


Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.